Labrafil M 2125 CS

Labrafil M 2125 CS
Product Description

Labrafil® M 2125 CS (linoleoyl Polyoxyl-6 glycerides) is a nonionic water-dispersible surfactant for lipid-based formulations to solubilize and increase oral bioavailability of poorly water-soluble APIs. Self-emulsifies in aqueous media forming a coarse dispersion, i.e., emulsion (SEDDS). Co-emulsifier in topical formulations to improve stability of emulsions.

Gattefosse S.A.

  • Country/Region:
    France
  • On CPHI since:
    2015
  • Employees:
    250 - 499
Company types
Manufacturer/Innovator

Gattefosse S.A.

  • Country/Region:
    France
  • On CPHI since:
    2015
  • Employees:
    250 - 499
Company types
Manufacturer/Innovator

More Products from Gattefosse S.A. (46)

  • Gelucire 43/01

    Product Gelucire 43/01

    Gelucire® 43/01 is a glyceride with an intermediate melting point used as a matrix agent for sensitive APIs and a viscosity-increasing agent in oral and topical formulations.

  • Gelucire 44/14

    Product Gelucire 44/14

    Gelucire® 44/14 (lauroyl polyoxyl-32 glycerides) is a nonionic water-dispersible surfactant for lipid-based formulations to solubilize and increase oral bioavailability of poorly water-soluble APIs. Self-emulsifies in aqueous media forming a fine dispersion, i.e., microemulsion (SMEDDS).
  • Gelucire 50/13

    Product Gelucire 50/13

    Gelucire® 50/13 (stearoyl polyoxyl-32 glycerides) is a nonionic water-dispersible surfactant for lipid-based formulations to solubilize and increase oral bioavailability of poorly water-soluble APIs. Self-emulsifies in aqueous media forming a fine dispersion, i.e., microemulsion (SMEDDS).

  • Labrafac lipophile WL 1349

    Product Labrafac lipophile WL 1349

    Labrafac™ lipophile WL 1349 is an oily vehicle and solubilizer of lipophilic APIs for oral, topical, and parenteral lipid-based formulations (LBFs).
  • Labrafac PG

    Product Labrafac PG

    Labrafac™ PG is a an oily vehicle and solubilizer for lipophilic APIs in topical dosage forms. Widely used as a vehicle in veterinary parenteral formulations.

  • Labrafil M 1944 CS

    Product Labrafil M 1944 CS

    Labrafil® M 1944 CS (oleoyl polyoxyl-6 glycerides ) is a nonionic water-dispersible surfactant for lipid-based formulations to solubilize and increase oral bioavailability of poorly water-soluble APIs. Self-emulsifies in aqueous media forming a coarse dispersion, i.e., emulsion (SEDDS). Co-emulsifier ...
  • Labrafil M 2130 CS

    Product Labrafil M 2130 CS

    Labrafil® M 2130 CS (lauroyl polyoxyl-6 glycérides) is a nonionic water-dispersible surfactant for lipid-based formulations to solubilize and increase oral bioavailability of poorly soluble APIs. Self-emulsifies in aqueous media forming a coarse dispersion, i.e., emulsion (SEDDS). Co-emulsifier in topical ...
  • Labrasol

    Product Labrasol

    Labrasol® is a non ionic oil-in-water surfactant used as solubilizer in topical formulations. Solubilizer and O/W surfactant for microemulsion.Able to form light foams with pump device (no gas required).
  • Labrasol ALF

    Product Labrasol ALF

    Labrasol® ALF (caprylocaproyl Polyoxyl-8 glycérides) is a nonionic water-dispersible surfactant for lipid-based formulations to solubilize and increase oral bioavailability of poorly water-soluble APIs. Self-emulsifies in aqueous media forming a fine dispersion, i.e., microemulsion (SMEDDS).

  • Lauroglyco 90

    Product Lauroglyco 90

    Lauroglycol™ 90 (propylene glycol monolaurate) is a nonionic water-insoluble surfactant used as cosurfactant in oral lipid-based formulation SEDDS and SMEDDS. Cosurfactant and solubilizer in topical dosage forms.

  • Lauroglycol FCC

    Product Lauroglycol FCC

    Lauroglycol™ FCC is a nonionic water-insoluble surfactant used as cosurfactant in oral lipid-based formulation SEDDS and SMEDDS. Cosurfactant and solubilizer in topical dosage forms associated with skin penetration enhancement.

  • Monosteol

    Product Monosteol

    Monosteol™ is a lipidic vehicle used as consistency agent in topical formulations. Enhances stability by preventing phase separation and oil droplet coalescence.

Gattefosse S.A. resources (5)

  • News Gelucire® 59/14, solid surfactant for oral bioavailability enhancement

    Discover Gelucire® 59/14, an add-on in Gattefossé Gelucire® range, for oral bioavailability enhancement
  • Brochure Selecting the best excipients to optimize drug delivery

    Providing high-quality functional excipients

    Our lipid excipients are manufactured using vegetable oils (including corn, apricot kernel or coconut oil), a wide array of plant-derived fatty acids, and alcohols such as polyglycerol, fatty alcohols, polyethylene glycol and propylene glycol.

    Depending on the raw materials used, the esterification reaction leads to solid, semi-solid, or liquid excipients. The fatty acid chain length, the composition in terms of mono-, di- and triglycerides and alcohol-esters impact the end-product physico-chemical and functional properties.

     
    Find out quickly the excipient you are looking for! This updated version has been enriched with the precedence of use of our excipients.
  • News Boost your drug bioavailability with Labrafac™ MC60

    Discover Labrafac™ MC60, glycerol monocaprylocaprate, an oral bioavailability enhancer.
  • Video Technical Centers of Excellence | Gattefossé

    The four Technical Centers of Excellence of Gattefossé, based in France, the United States, China and India, help our customers worldwide in their formulation projects, from concept to commercialization. Their core missions are to provide technical support, troubleshoot and share their scientific knowledge on the use of lipid-based excipients.
  • News Innovate in bi-gel with Emulfree® Duo

    Discover our brand new excipient Emulfree® Duo, a ready-to-use stabilizing agent, enabler of bi-gel, an emerging topical dosage form.